Investigating oral blarcamesine for treatment of early Alzheimer’s disease

Abarajithan Chandrasekaran, Alexandra Paget-Blanc, Boris Decourt, Marwan N. Sabbagh

Open source

DOI
10.1080/14656566.2026.2732056
Published
2026-09-20
Container
Expert Opinion on Pharmacotherapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2026.2732056,
  title = {Investigating oral blarcamesine for treatment of early Alzheimer’s disease},
  author = {Abarajithan Chandrasekaran and Alexandra Paget-Blanc and Boris Decourt and Marwan N. Sabbagh},
  year = {2026},
  journal = {Expert Opinion on Pharmacotherapy},
  doi = {10.1080/14656566.2026.2732056},
  url = {https://doi.org/10.1080/14656566.2026.2732056}
}

RIS

TY  - JOUR
TI  - Investigating oral blarcamesine for treatment of early Alzheimer’s disease
AU  - Abarajithan Chandrasekaran
AU  - Alexandra Paget-Blanc
AU  - Boris Decourt
AU  - Marwan N. Sabbagh
PY  - 2026
JO  - Expert Opinion on Pharmacotherapy
DO  - 10.1080/14656566.2026.2732056
UR  - https://doi.org/10.1080/14656566.2026.2732056
ER  - 

APA

Chandrasekaran, A., Paget-Blanc, A., Decourt, B., & Sabbagh, M. N. (2026). Investigating oral blarcamesine for treatment of early Alzheimer’s disease. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2026.2732056

Source records